SCHEMBL26645653

SCHEMBL26645653

CCc1cc(-c2nn3c(c2-c2ccncc2)CN(C(=O)OC(C)(C)C)CC3)ccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1E P49674 8/20 0.41
CSNK1D P48730 7/20 0.41
CACNB4 O00305 1/20 0.39
CACNA1A O00555 1/20 0.39
CACNA1G O43497 1/20 0.39
CACNG3 O60359 1/20 0.39
CACNA1F O60840 1/20 0.39
CACNA1H O95180 1/20 0.39
CACNB3 P54284 1/20 0.39
CACNA2D1 P54289 1/20 0.39
CACNG7 P62955 1/20 0.39
CACNA1B Q00975 1/20 0.39
CACNA1D Q01668 1/20 0.39
CACNB1 Q02641 1/20 0.39
CACNG1 Q06432 1/20 0.39
CACNB2 Q08289 1/20 0.39
CACNA1S Q13698 1/20 0.39
CACNA1C Q13936 1/20 0.39
CACNA1E Q15878 1/20 0.39
CACNA2D4 Q7Z3S7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30622825 0.91 CSNK1E (0.43) CSNK1ECSNK1DGPR119POLBMEN1
SCHEMBL26645014 0.91 CSNK1E (0.43) CSNK1ECSNK1DGPR119POLBMEN1
SCHEMBL26645805 0.89 CSNK1E (0.42) CSNK1ECSNK1DGPR119POLBMEN1
SCHEMBL26645275 0.89 CSNK1E (0.43) CSNK1ECSNK1DGPR119
SCHEMBL26645053 0.86 CSNK1D (0.46) CSNK1ECSNK1DGPR119C5AR1CKS1B
SCHEMBL30622922 0.86 CSNK1E (0.43) CSNK1ECSNK1DPOLBMEN1KMT2A
SCHEMBL26645443 0.86 CSNK1E (0.43) CSNK1ECSNK1DPOLBMEN1KMT2A
SCHEMBL26645019 0.86 CSNK1D (0.47) CSNK1ECSNK1DCACNB4CACNA1ACACNA1G
SCHEMBL30622740 0.86 CFTR (0.42) CSNK1ECSNK1DCACNB4CACNA1ACACNA1G
SCHEMBL26645587 0.86 CFTR (0.42) CSNK1ECSNK1DCACNB4CACNA1ACACNA1G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 EP disclosed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 WO disclosed